Vaishali Pharma
Vaishali Pharma Performance
Day Range
- Low 141.00
- High 147.00
52 Week Range
- Low 114.85
- High 193.75
- Open Price142.35
- Previous Close142.05
- Volume148803
Start SIP in Vaishali Pharma
Start SIPVaishali Pharma Investment Rating
-
Master Rating:
-
Vaishali Pharma has an operating revenue of Rs. 72.31 Cr. on a trailing 12-month basis. An annual revenue de-growth of -7% needs improvement, Pre-tax margin of 13% is healthy, ROE of 16% is good. The company has a reasonable debt to equity of 13%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 200DMA and around 5% above its 50DMA. It needs to stay above the 200DMA levels to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 85 which is a GOOD score indicating consistency in earnings, a RS Rating of 33 which is POOR indicating the underperformance as compared to other stocks, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 73 indicates it belongs to a poor industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has declined in the last reported quarter is a negative sign. Overall, the stock is lagging behind in some of the technical parameters, but great earnings make it a stock to examine in more detail.
EPS Strength
Price Strength
Buyer Demand
Group Rank
Indicator | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | Jun 2022 | Mar 2022 |
---|---|---|---|---|---|---|---|
Oper Rev Qtr Cr | 13 | 13 | 26 | 20 | 13 | 10 | 22 |
Operating Expenses Qtr Cr | 10 | 11 | 25 | 17 | 11 | 8 | 25 |
Operating Profit Qtr Cr | 3 | 2 | 1 | 4 | 3 | 2 | 1 |
Depreciation Qtr Cr | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Interest Qtr Cr | 0 | 0 | 1 | 0 | 1 | 1 | 1 |
Tax Qtr Cr | 1 | 1 | 0 | 1 | 1 | 1 | 0 |
Net Profit Qtr Cr | 2 | 2 | 0 | 3 | 2 | 2 | 0 |
Vaishali Pharma Technicals
EMA & SMA

- Bullish Moving Average
- ___
- 16
- Bearish Moving Average
- ___
- 0
- 20 Day
- ₹137.86
- 50 Day
- ₹135.34
- 100 Day
- ₹133.82
- 200 Day
- ₹130.80
- 20 Day
- ₹137.67
- 50 Day
- ₹134.20
- 100 Day
- ₹131.67
- 200 Day
- ₹137.10
Vaishali Pharma Resistance and Support
Resistance | |
---|---|
First Resistance | 145.20 |
Second Resistance | 149.10 |
Third Resistance | 151.20 |
RSI | 58.64 |
MFI | 66.46 |
MACD Single Line | 1.05 |
MACD | 1.47 |
Support | |
---|---|
First Resistance | 139.20 |
Second Resistance | 137.10 |
Third Resistance | 133.20 |
Vaishali Pharma Delivery and Volume
Period | NSE + BSE Volume Avg | NSE + BSE Delivery Volume Avg | NSE + BSE Delivery Volume % |
---|---|---|---|
Day | 148,803 | 7,148,496 | 48.04 |
Week | 128,823 | 6,465,601 | 50.19 |
1 Month | 47,056 | 2,641,232 | 56.13 |
6 Month | 104,040 | 5,714,911 | 54.93 |
Vaishali Pharma Result Highlights
Vaishali Pharma Synopsis
NSE-Medical-Diversified
Vaishali Pharma is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 69.66 Cr. and Equity Capital is Rs. 10.55 Cr. for the Year ended 31/03/2023. Vaishali Pharma Ltd. is a Public Limited Listed company incorporated on 25/03/2008 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L52310MH2008PLC181632 and registration number is 181632.Market Cap | 150 |
Sales | 72 |
Shares in Float | 0.77 |
No of funds | |
Yield |
Book Value | 3.68 |
U/D Vol ratio | 1.1 |
LTDebt / Equity | 13 |
Alpha | 0.06 |
Beta | 0.29 |
Vaishali Pharma
Owner Name | Sep-23 | Jun-23 | Mar-23 | Dec-22 |
---|---|---|---|---|
Promoters | 26.62% | 26.74% | 26.74% | 26.74% |
Mutual Funds | ||||
Insurance Companies | ||||
Foreign Portfolio Investors | ||||
Financial Institutions/ Banks | ||||
Individual Investors | 62% | 65.97% | 64.92% | 62.85% |
Others | 11.38% | 7.29% | 8.34% | 10.41% |
Vaishali Pharma Management
Name | Designation |
---|---|
Mr. Atul Vasani | Chairman & Managing Director |
Mr. Dewansh Vasani | Executive Director |
Mrs. Jagruti Vasani | Whole Time Director |
Mr. Ashvin Ganatra | Independent Director |
Mr. Manish Ved | Independent Director |
Mr. Pratik Jakhelia | Independent Director |
Vaishali Pharma Forecast
Price Estimates
Vaishali Pharma Corporate Action
Date | Purpose | Remarks |
---|---|---|
2023-05-22 | Audited Results | |
2022-11-03 | Quarterly Results | |
2022-07-25 | Quarterly Results | |
2022-05-30 | Audited Results | |
2022-05-04 | Others | To consider raising of funds issue in the ratio of 3:5 of Rs. 10/- |
Vaishali Pharma FAQs
What is Share Price of Vaishali Pharma ?
Vaishali Pharma share price is ₹141 As on 03 December, 2023 | 05:23
What is the Market Cap of Vaishali Pharma ?
The Market Cap of Vaishali Pharma is ₹149.7 Cr As on 03 December, 2023 | 05:23
What is the P/E ratio of Vaishali Pharma ?
The P/E ratio of Vaishali Pharma is 23.4 As on 03 December, 2023 | 05:23
What is the PB ratio of Vaishali Pharma ?
The PB ratio of Vaishali Pharma is 3.7 As on 03 December, 2023 | 05:23